Can Fatigability Neuromuscular Explain Chronic Fatigue in People With
Can Fatigability Neuromuscular Explain Chronic Fatigue in People With Multiple Sclerosis?
What it found
The trial ended early for another reason (see below).
Reason given: low inclusion rates
This trial finished 5 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- Evaluation of degree chronic fatigue.
Given to everyone in the trial
- Questionnaires
- Blood sample
- Cardiopulmonary evaluation
- Capacity of muscular oxygen extraction
- Sleep assessment
- Metabolic fatigue
- Neuromuscular evaluation
What it measured
Main measures
Voluntary maximum contraction
Day : 30
Other measures (12)
Neuromuscular function during the dynamic strenuous exercise
Day : 30
Physical functionNerve conduction testsMuscle oxygen extraction capacity
Day : 30
Anemia
Day : 30
Inflammation
Day : 30
VO2 max
Day : 30
Physical functionHeart rate
Day : 30
Cognitive fatigue
Day : 30
Thinking and memoryFatiguePerceived fatigue
Day : 30
FatigueThermoregulation
Day : 30
Sleep quality
Day : 30
Mood and sleep
Who could take part
MS (type not specified) · 18 to 70
Show the full criteria
Inclusion criteria
For Patients: * Aged ≥ 18 and ≤ 70 years * Men or women * With multiple sclerosis since 2 and 25 years * Affiliates or beneficiaries of social security scheme * Signed consent For Healthy volunteers: * Aged ≥ 18 and ≤ 70 years * Men or women * Matched in accordance with age, sex and level of physical activity
Exclusion criteria
For Patients and Healthy volunteers: * High heart rate resting * Blood pressure > 144/94 mmHg * Recent adjustment of drug or drug can have an impact on fatigue or stimulant for fatigue * Taking neuroactive substances that can alter corticospinal excitability * Contraindication at application magnetic field * Contraindication at Magnetic Resonance Imaging (MRI) * Currently participating in a structured exercise program * Pregnant For Patients only: * Spasticity or cerebellar ataxia * Abnormal range of motion (toe and/or ankle) * Musculoskeletal injuries that impedes pedaling * Appearance of symptoms of multiple sclerosis in the 90 days preceding the study For Healthy volunteers: - Neurological diseases, cardiovascular, musculoskeletal
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Chronic fatigue is the most common and debilitating symptom in multiple sclerosis patients. This chronic fatigue affects their quality of life by decreasing their capacity to perform simple tasks of daily life. The aim of the present project is to determine whether deteriorated neuromuscular function (i.e. increased fatigability) is involved in this feeling of chronic fatigue. Because the causes of this feeling are multi-dimensional, a large battery of tests will allow us to better understand the origin of chronic fatigue. A better knowledge of chronic fatigue etiology will allow to optimize rehabilitation treatments to decrease the apparition/persistence of chronic fatigue and in fine improve quality of life.
Loading reviews and guidelines…
History
Started
Jan 2020
Main results due
Jun 2021
Finished
Jul 2021